Please Wait
Applying Filters...
menu
    • menu
    Veranova: A CDMO that manages complexity with confidence.

    Virtual Booth

    Contact Supplier

    Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-08-25

    Virtual Booth

    An Enquiry

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-08-25

    Virtual Booth

    An Enquiry

    Menu

    L Histidine Hydrochloride Monohydrate

    INACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS BY APPLICATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 2COSENTYX

    02 1DARZALEX

    03 1GAMIFANT

    04 1IMJUDO

    05 1ONTRUZANT

    06 1OPDUALAG

    07 1SYLVANT

    08 1VYEPTI

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers

    01

    ASTRAZENECA AB

    Tremelimumab-actl

    EPSC
    Not Confirmed
    arrow

    02

    BRISTOL MYERS SQUIBB

    Nivolumab;Relatlimab-rmbw

    EPSC
    Not Confirmed
    arrow

    03

    JANSSEN BIOTECH

    Daratumumab

    EPSC
    Not Confirmed
    arrow

    04

    05

    NOVARTIS PHARMS CORP

    Secukinumab

    EPSC
    Not Confirmed
    arrow

    06

    NOVARTIS PHARMS CORP

    Secukinumab

    EPSC
    Not Confirmed
    arrow

    07

    NOVIMMUNE S.A.

    Emapalumab-lzsg

    EPSC
    Not Confirmed
    arrow

    08

    SAMSUNG BIOEPIS CO LTD

    Trastuzumab-dttb

    EPSC
    Not Confirmed
    arrow

    09

    RECORDATI RARE DISEASES, INC.

    Siltuximab

    EPSC
    Not Confirmed
    arrow
    RECORDATI RARE DISEASES, INC.
    arrow
    EPSC
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    SILTUXIMAB

    Drug : SYLVANT

    Dosage Form : INJECTABLE; INJECTION

    Application Number : 125496

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF